Business and Earnings Impact of the Spread of COVID-19
First written in FY2021. 6 of 11 entries say "Materialised", first in FY2022-Q2. Latest entry: FY2025.
The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.
- FY2025ReframedAnnual report
「Although we are developing a crisis management structure and taking measures in preparation for emergencies, if natural disasters such as major earthquakes and typhoons, accidents, fires or infectious disease outbreaks including COVID-19 occur on a scale far exceeding expectations and cause unforeseen events such as business or service interruptions, facility damage or restrictions on electricity supply, our group’s ability to provide its businesses and services could be disrupted.」
The disclosure was reorganized from specific COVID-19 revenue impacts into a general business continuity risk covering natural disasters, accidents and infectious diseases. - FY2024-H1MaterialisedAnnual report
「In the medical career support business during the interim consolidated accounting period, vaccination-related revenue disappeared because local-government COVID-19 vaccination programs had almost ended.」
The end of COVID-19 vaccination programs eliminated the related revenue during the interim period. - FY2024-Q1MaterialisedAnnual report
「Related revenue declined because local-government COVID-19 vaccination programs had almost ended.」
The end of vaccination programs resulted in a decline in related revenue in the first quarter of 2024. - FY2023MaterialisedAnnual report
「Revenue from physician placements related to establishing vaccination systems at local governments and workplaces declined compared with the previous consolidated fiscal year.」
The shift of COVID-19 to Category V infectious disease reduced vaccination-related physician placement revenue during the full year, while the mental health solutions business grew. - FY2023-Q3MaterialisedAnnual report
「Although revenue from placement fees for medical personnel related to vaccinations fell substantially because COVID-19 was reclassified as a Category V infectious disease, order-taking activity in our core mental health solutions business became more active as economic activity resumed.」
The reclassification of COVID-19 as a Category V infectious disease materially reduced vaccination-related medical personnel placement revenue, while the resumption of economic activity increased order-taking activity in the mental health solutions business. - FY2023-Q2MaterialisedAnnual report
「Although revenue from placement fees for medical personnel related to vaccinations fell substantially because COVID-19 was reclassified as a Category V infectious disease, order-taking activity in our core mental health solutions business became more active as economic activity resumed.」
The reclassification of COVID-19 as a Category V infectious disease materially reduced vaccination-related medical personnel placement revenue, while the resumption of economic activity increased order-taking activity in the mental health solutions business. - FY2023-Q1RestatedAnnual report
「Further spread of COVID-19 could affect our group’s business performance and financial condition depending on how the situation develops, and we will continue to monitor it closely.」
The company continued disclosing the potential impact of further disease spread, while stating that there were no new business risks or material changes from the previous consolidated fiscal year. - FY2022-Q3RestatedAnnual report
「The delay in economic recovery caused by the impact of COVID-19 and the sharp depreciation of the yen, which raised resource and raw material prices, continued. New business discussions and order-taking activities were somewhat more subdued than initially planned. Some existing customers also temporarily suspended or canceled services because of deteriorating business performance and other reasons.」
The company continued to report delayed economic recovery, restrained new business and order-taking activity, and service suspensions and cancellations by existing customers. - FY2022-Q2MaterialisedAnnual report
「The delay in economic recovery caused by COVID-19 continued during the second quarter cumulative period, and new business discussions and order-taking activities remained somewhat subdued. Some existing customers also temporarily suspended or canceled services because of deteriorating business performance.」
The company continued to experience delayed economic recovery, restrained new business and order-taking activity, and service suspensions and cancellations by existing customers. As of the filing date, no material business impact had arisen and accounting estimates assumed only a minor impact. - FY2022-Q1RestatedAnnual report
「Further spread of COVID-19 could affect our group’s business performance and financial condition depending on how the situation develops, and we will continue to monitor it closely.」
The company stated that there were no new risks or material changes, while continuing to disclose the possibility that further spread of the disease could affect results and financial condition. - FY2021First statedAnnual report
「Some existing customers whose business performance deteriorated temporarily suspended or canceled our services.」
As the pandemic persisted, some customers in the mental health business suspended or canceled services, while medical institution job openings declined in the medical career support business. Physician placements related to vaccinations contributed to revenue.